We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

November 30, 2009

TEVA PHARMACEUTICALS USA, INC. v. AMGEN INC.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 15, 2011

    Amgen, Teva Settle Patent Suit Over Neopogen Generic

    A Pennsylvania federal judge on Friday approved a settlement between generics maker Teva Pharmaceuticals USA Inc. and Amgen Inc. that squashes Teva's hopes of marketing a copycat version of the blood drug Neopogen until 2013.

1 other articles on this case. View all »

Parties

To view the parties, register now.